CA Stock MarketDetailed Quotes
MYCO Mydecine Innovations Group Inc
- 0.010
- +0.005+100.00%
15min DelayMarket Closed Nov 5 15:54 ET
617.55KMarket Cap-66P/E (TTM)
0.010High0.005Low885.22KVolume0.010Open0.005Pre Close8.09KTurnover0.14552wk High1.43%Turnover Ratio61.76MShares0.00552wk Low-0.15EPS TTM617.55KFloat Cap0.200Historical HighLossP/E (Static)61.76MShs Float0.005Historical Low-0.68EPS LYR100.00%Amplitude--Dividend TTM-0.04P/B1Lot Size--Div YieldTTM
About Mydecine Innovations Group Inc Company
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Company Profile
SymbolMYCO
Company NameMydecine Innovations Group Inc
Founded2013
MarketCNQ
Employees3
Fiscal Year Ends12-31
Address1890 – 1075 West Georgia Street Suite 810
CityVancouver
CountryCAN
Zip CodeV6E 3C9
Phone+1 888 871-393
Websitehttps://www.mydecine.com
Company Executives
- Name
- Position
- Salary
- David Joshua Bartch
- Director and Chief Executive Officer
- --
- Robert Roscow
- Director and Chief Scientific Officer
- --
- Dr. Rakesh Jetly
- Chief Medical Officer
- --
- Dean Ditto
- Chief Financial Officer
- --
- Damon Michaels
- Director and Chief Operating Officer
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data